Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.
Capital Increase for stellacure GmbH
March 2010. Corporate Finance Partners CFP BioConnect AG – now ACXIT Capital Partners – advises stellacure GmbH on a strategic transaction with Cord Blood America, Inc.
CFP BioConnect advised German cord blood bank stellacure GmbH (www.stellacure.com) on a transaction, under which Cord Blood America, Inc. (www.cordblood-america.com), one of America’s largest umbilical cord blood stem cell preservation company will acquire a majority stake in the Hamburg-based company.
stellacure GmbH is not only one of the most meaningful players in the German cord blood market, but also has established strong cooperations with sales partners in Spain and Italy. These collaborations have already resulted into a strong flow of cord blood storages from these countries. stellacure is the first private blood storage bank that entertains a corporation with the Blood Donor Service Baden-Württemberg-Hessen, part of the German Red Cross and one of the largest and most experienced institutions of its kind, not only in Germany but also in Europe.
The partnership with Cord Blood America positions stellacure uniquely to further grow its business in Germany and in other parts of Europe. For Cord Blood America, this transaction represents the entry into the largest single European market and an excellent platform to expand its presence in other European markets. The deal is a major step for the company to achieve its objective to become the leading stem cell storage player globally.
This transaction furthermore demonstrates the ability of CFP BioConnect and the Corporate Finance Partners Group to initiate and execute transactions in the Life Sciences sector on an international level. It also strengthens the Group’s M&A track record involving transaction partners on both sides of the Atlantic.
Corporate Finance Partners CFP BioConnect – now ACXIT Capital Partners – acted as the adviser to stellacure.
About ACXIT Capital Partners
ACXIT Capital Partners is a leading international corporate finance and investment advisory firm for mid-market clients and entrepreneurs in Europe and beyond. Since 1998, we offer our clients comprehensive corporate finance advisory services including M&A and capital markets advisory as well as restructuring, debt and strategic advisory. As an independent, privately owned firm we maintain offices in Frankfurt, Berlin, Munich, Zurich, Vienna and Hong Kong as well as strong alliances in China, India and the USA.
To date, we have completed more than 350 transactions with a total deal/financing volume of approx. EUR 17bn. Our clients are corporations, family-owned businesses, entrepreneurs, financial sponsors and family offices. While our home market is in the German speaking region, most clients are international and transactions cross-border. (www.acxit.com)
ACXIT Capital Holding GmbH
60323 Frankfurt am Main
Dr. Ingmar Ackermann, Managing Partner